Amneal Pharmaceuticals, Inc. (AMRX) — Stock Score Summary

Amneal Pharmaceuticals, Inc. (AMRX) has a MoatMap StockRank of 92/100 based on Quality (55/100), Value (48/100), and Momentum (76/100) factor scores. The current signal is STRONG BUY. Generic drug manufacturer with thin margins and high input costs, lacking the pricing power and regulatory moats of high-utilization CDMOs.

Amneal Pharmaceuticals, Inc. is a U.S. pharmaceutical company engaged in the development, manufacturing, and distribution of a broad portfolio of generic and specialty pharmaceutical products. The company's competitive strength lies in its expansive generic pipeline, efficient manufacturing infrastructure, and a growing presence in complex generics, biosimilars, and specialty branded products. This diversified approach allows it to address a wide range of therapeutic areas and market opportunities.

Key Financial Metrics

Price$12.88
Market Cap$4.1B
P/E (TTM)34.57
P/E (Forward)11.06
Price/Book-90.07
Return on Invested Capital13.6%
Debt/Equity6750.84
Gross Margin39.2%
Operating Margin19.6%
Revenue Growth3.9%
Free Cash Flow$101M

Amneal Pharmaceuticals, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Amneal Pharmaceuticals, Inc.’s (AMRX) StockRank?
MoatMap’s StockRank for Amneal Pharmaceuticals, Inc. (AMRX) is 92/100, with a Strong Buy signal. It is a composite of Quality (55), Value (48), and Momentum (76) factor ranks across MoatMap’s 19,000+ stock universe.
Does Amneal Pharmaceuticals, Inc. have an economic moat?
Amneal Pharmaceuticals, Inc. (AMRX) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Amneal Pharmaceuticals, Inc. a buy, hold, or sell?
MoatMap’s current signal for Amneal Pharmaceuticals, Inc. (AMRX) is Strong Buy, based on a StockRank of 92/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Amneal Pharmaceuticals, Inc. in?
Amneal Pharmaceuticals, Inc. (AMRX) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksAMRX deep dive reportAI ChampionsHow we score stocksSense-check another stock